Get the Stockscreener App
11.76
2.31%
0.265
Jatt Ii Acquisition Corp stock is traded at $11.76, with a volume of 10,494.
It is up +2.31% in the last 24 hours and up +11.00% over the past month.
JATT II Acquisition Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
See More
Previous Close:
$11.49
Open:
$11.5
24h Volume:
10,494
Relative Volume:
0.78
Market Cap:
$94.37M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+13.08%
1M Performance:
+11.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$11.50
$11.98
1-Week Range:
$10.40
$12.25
52-Week Range:
$10.00
$12.25
Jatt Ii Acquisition Corp Stock (JATT) Company Profile
Name
Jatt Ii Acquisition Corp
Sector
Industry
Phone
201-688-0364
Address
C/O APPLEBY GLOBAL SERVICES (CAYMAN) LTD, GEORGE TOWN
Compare JATT vs LION, XXI, CCXI, UMAC, DMII
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
JATT
Jatt Ii Acquisition Corp
|
11.76 | 91.16M | 0 | 0 | 0 | 0.00 |
LION
Lionsgate Studios Corp
|
14.66 | 4.45B | 2.63B | -175.60M | 11.40M | -0.7173 |
XXI
Twenty One Capital Inc
|
5.42 | 1.72B | 0 | 4.35M | 456.40K | 0.3397 |
CCXI
Churchill Capital Corp Xi
|
19.10 | 971.97M | 0 | 0 | 0 | 0.0647 |
UMAC
Unusual Machines Inc
|
22.08 | 1.07B | 17.25M | -5.64M | -40.16M | -0.3337 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.09 | 640.82M | 0 | 8.58M | -1.11M | 0.134 |
Jatt Ii Acquisition Corp Stock (JATT) Latest News
JATTJatt II Acquisition Corp Revenue Breakdown - Finviz
JATT II Acquisition (JATT) sponsor forfeits 225,000 shares after over-allotment expiry - Stock Titan
JATT II Acquisition Corp. (JATT) sponsor forfeits 225,000 Ordinary Shares - Stock Titan
Talawar Therapeutics to debut on Nasdaq with $285m as Dupixent challenger - Yahoo Finance
Price to book forward of JATT II Acquisition Corp – NASDAQ:JATT - TradingView
Talawar (NASDAQ: TLWR) to Merge with JATT II; $285M Expected - Stock Titan
Price to sales forward of JATT II Acquisition Corp – NASDAQ:JATT - TradingView
Talawar Therapeutics and JATT II Announce $285M Merger to Advance Bispecific Antibody for Atopic Dermatitis - Minichart
Talawar–JATT II deal includes $225M PIPE (NASDAQ: JATT) - Stock Titan
Talawar Tx launches as publicly traded biotech - The Pharma Letter
Enterprise value to revenue forward of JATT II Acquisition Corp – NASDAQ:JATT - TradingView
Enterprise value to EBIT forward of JATT II Acquisition Corp – NASDAQ:JATT - TradingView
JATT II Acquisition to Merge With Talawar Tx; JATT to Become Subsidiary in SPAC Deal - TradingView
Talawar, JATT II (Nasdaq: JATT) unveil $225M PIPE-backed biotech merger - Stock Titan
JATT II Acquisition, Talawar Therapeutics announce combination agreement - TipRanks
'There's room for multiple winners': Talawar heads to Nasdaq via SPAC deal to bankroll eczema asset - Fierce Biotech
Talawar Tx Inc. entered into a definitive business combination agreement to acquire JATT II Acquisition Corp. from JATT Ventures II L.P. in a reverse merger transaction. - marketscreener.com
JATT II ACQUISITION CORP (JATT) Stock Chart - ChartMill
OCAC.U Stock Fund Price and Chart — BOATS:OCAC.U - TradingView
JATT Price Today: JATT II Acquisition Corp. Stock Price, Quote & Chart | MEXC - MEXC Exchange
BermudaAppleby Advises Amanat Acquisition In Its USD75M Initial Public Offering - Mondaq
JATT II Acquisition Corp 2026 Q1 SEC Filing: Financials, Management Discussion, and Regulatory Disclosures - Minichart
JATT II Acquisition Corp. 1Q 2026: Net income $(68,793), EPS $(0.05) — 10-Q Summary - TradingView
JATT II Acquisition Corp (NASDAQ: JATT) files 10-Q after $60M SPAC IPO - Stock Titan
Cayman IslandsAppleby Advises JATT II Acquisition Corp In Its USD60M Initial Public Offering - Mondaq
Oaktree’s OACC SPAC Looks Quiet. The October Deadline Is the Real Story - Bez Kabli
RESEARCH ALLIANCE CORPORATION III ANNOUNCES PRICING OF $75 MILLION INITIAL PUBLIC OFFERING - Yahoo Finance
JATT II Acquisition (JATT) Stock Analysis Report | Financials & Insights - Benzinga
JATT II Acquisition Corp (JATT) Price To Free Cash Flow - Zacks Investment Research
GUACU|Berto Acquisition II Units (Proposed)|Price:10.065|Chg%:0.04 - TradingKey
JATT Acquisition (JATT) Stock Price, News & Analysis $JATT - MarketBeat
JATT Technical Analysis & Stock Price Forecast - Intellectia AI
Number of shareholders of JATT II Acquisition Corp – NASDAQ:JATT - TradingView
JATT II Acquisition Corp (JATT) Price To Cash Flow - Zacks Investment Research
OTAI_u|OTAI_u.NB|Price:10.074|Chg%:0.02 - TradingKey
BWIV|Blue Water Acquisition IV Redeemable Units|Price:9.905|Chg%:-0.02 - TradingKey
SAGU_u|SAGU_u.NB|Price:10.080|Chg%:-0.03 - TradingKey
JATT Stock Price, Quote & Chart | JATT II ACQUISITION CORP (NASDAQ:JATT) - ChartMill
JATT|JATT II Acquisition Ord Shs|Price:10.520|Chg%:0.02 - TradingKey
WENC_u|West Enclave Merger Units (Proposed)|Price:10.090|Chg%:0.09 - TradingKey
GLND Stock Price and Chart — NASDAQ:GLND - TradingView
RA Capital-backed holders report 500,000 shares in JATT II (JATT) - Stock Titan
JATT SEC FilingsJatt Ii Acquisition Corp 10-K, 10-Q, 8-K Forms - Stock Titan
JATT II Acquisition Corp 2026 Balance Sheet and Financial Statement Overview - Minichart
JATT II Acquisition completes $63M IPO and private placement, places $60M in trust - TradingView
JATT II Acquisition (Nasdaq: JATT) closes $60,000,000 IPO and funds trust - Stock Titan
Commodore reports 500,000-share (6.4%) stake in JATT II (NASDAQ: JATT) - Stock Titan
Great Point, Dr. Jay & Nordahl report 6.41% stake in JATT (NYSE: JATT) - Stock Titan
AMAN Stock Price and Chart — NASDAQ:AMAN - TradingView
JATT II Acquisition (JATT) sponsor adds 300,000 private placement shares - Stock Titan
JATT (JATT) CEO-linked sponsor adds 300K private placement shares - Stock Titan
Jatt Ii Acquisition Corp Stock (JATT) Financials Data
There is no financial data for Jatt Ii Acquisition Corp (JATT). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.25%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):